Dipeptidyl peptidase IV (DPPIV/CD26) inhibition does not improve engraftment of unfractionated syngeneic or allogeneic bone marrow after nonmyeloablative conditioning

In order to develop minimally toxic bone marrow transplantation (BMT) protocols suitable for use in a wider range of indications, it is important to identify ways to enhance BM engraftment at a given level of recipient conditioning. CXCL12/stromal cell-derived factor-1α plays a crucial physiological...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwaiger, Elisabeth, Klaus, Christoph, Matheeussen, Veerle, Baranyi, Ulrike, Pilat, Nina, Ramsey, Haley, Korom, Stephan, De Meester, Ingrid, Wekerle, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Inc 2012
Materias:
Experimental Stem Cell Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265670/
https://www.ncbi.nlm.nih.gov/pubmed/22085453
http://dx.doi.org/10.1016/j.exphem.2011.10.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265670/
https://www.ncbi.nlm.nih.gov/pubmed/22085453
http://dx.doi.org/10.1016/j.exphem.2011.10.010

Ejemplares similares